RT Journal Article
SR Electronic
T1 Individual and spatial determinants of mortality during the Covid-19 pandemic: The case of Belgium in 2020
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.09.04.23295014
DO 10.1101/2023.09.04.23295014
A1 Mélanie Bourguignon
A1 Aurélie Bertrand
A1 Joan Damiens
A1 Yoann Doignon
A1 Thierry Eggerickx
A1 Audrey Plavsic
A1 Jean-Paul Sanderson
YR 2023
UL http://medrxiv.org/content/early/2023/09/05/2023.09.04.23295014.abstract
AB Context The year 2020 was marked by the Covid-19 pandemic. In Belgium, it led to a doubling in deaths, mainly grouped into two periods. This article aims to compare the relative importance of predictors and individual and spatial determinants of mortality during these two waves to an equivalent non-pandemic period and to identify whether and to what extent the pandemic has altered the sociodemographic patterns of conventional mortality.Methods The analyses relate to all-cause mortality during the two waves of Covid-19 and their equivalent in 2019. They are based on matching individual and exhaustive data from the Belgian National Register with tax and population census data. A multi-level approach was adopted combining individual and spatial determinants.Results Mortality patterns during the pandemic are very similar to those observed outside the pandemic. As in 2019, age, sex, and household composition significantly determine the individual risk of dying, with a higher risk of death among the oldest people, men, and residents of collective households. However, their risk of death increases during the Covid period, especially in the 65–79 age group. Spatial information is no more significant in 2020 than in 2019. However, a higher risk of death is observed when the local excess mortality index or the proportions of isolated or disadvantaged people increase.Conclusions While the Covid pandemic did not fundamentally alter conventional mortality patterns, it did amplify some of the pre-existing differences in mortality.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by BELSPO and F.R.S.-FNRSAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesNo data produced in the present study are available